Journal rankings · indicator year 2008
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2008
Endocrinology, Diabetes and Metabolism journal rankings 2008
89 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 89 ranked journals in 2008. The median journal has an OJR of 0.91, below the world average of 1.00, down 0.03 on 2007; Q1 starts at OJR 1.44. The top three are Endocrine Reviews, Best Practice & Research Clinical Endocrinology & Metabolism, and Diabetes Care.
Ranks and citation indicators: 2008. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2005–2007, the window the 2008 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery474
- Pulmonary and Respiratory Medicine199
- Cardiology and Cardiovascular Medicine173
- Public Health, Environmental and Occupational Health173
- Oncology127
- Epidemiology114
- Infectious Diseases106
- Psychiatry and Mental health98
- Radiology, Nuclear Medicine and Imaging94
- Endocrinology, Diabetes and Metabolism89
- Physiology89
- Neurology85
Show all 42 subfields
- Orthopedics and Sports Medicine60
- Pediatrics, Perinatology and Child Health60
- Ophthalmology55
- Hematology52
- Dermatology50
- Obstetrics and Gynecology45
- Rheumatology38
- Nephrology33
- Pharmacology32
- Reproductive Medicine32
- Emergency Medicine29
- Complementary and alternative medicine28
- Geriatrics and Gerontology24
- Otorhinolaryngology21
- Pathology and Forensic Medicine18
- Rehabilitation18
- Immunology and Allergy15
- Critical Care and Intensive Care Medicine14
- Genetics11
- Anesthesiology and Pain Medicine9
- Hepatology9
- Urology8
- Gastroenterology7
- Internal Medicine4
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
89 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2007. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2005–2007, the window the 2008 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2005–2007 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2008. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 10.11Q1 | 20.75 1.90 down from 2007 | 104 | 64% | $3,750 | ||
2Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 3.55Q1 | 7.23 0.33 up from 2007 | 131 | 11% | $4,450 | ||
3Diabetes CareAmerican Diabetes Association · United States | 3.41Q1 | 7.65 0.87 down from 2007 | 2,231 | 76% | — | ||
4The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 3.01Q1 | 7.93 0.94 up from 2007 | 2,694 | 50% | $3,750 | ||
5DiabetologiaSpringer Science+Business Media · Germany | 2.74Q1 | 6.90 0.16 up from 2007 | 1,147 | 82% | $3,490 | ||
6Endocrine Related CancerBioscientifica · United Kingdom | 2.69Q1 | 6.61 0.05 up from 2007 | 289 | 92% | — | ||
7Journal of Internal MedicineWiley · United Kingdom | 2.39Q1 | 5.32 0.25 down from 2007 | 444 | 55% | $4,780 | ||
8Cardiovascular DiabetologyOABioMed Central · United Kingdom | 2.33Q1 | 4.44 1.29 down from 2007 | 84 | 100% | $4,290 | ||
9Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 2.19Q1 | 6.37 3.31 up from 2007 | 93 | 24% | $5,590 | ||
10EndocrinologyOxford University Press · United States | 2.05Q1 | 5.14 0.29 down from 2007 | 1,994 | 64% | $3,750 | ||
11Diabetes Obesity and MetabolismWiley · United Kingdom | 1.99Q1 | 4.94 0.90 up from 2007 | 342 | 13% | $5,380 | ||
12Clinical TherapeuticsElsevier BV · United States | 1.95Q1 | 3.99 0.12 down from 2007 | 647 | 6% | $4,240 | ||
13European Journal of EndocrinologyOxford University Press · United Kingdom | 1.83Q1 | 4.72 0.12 up from 2007 | 705 | 15% | $4,292 | ||
14Current Opinion in Endocrinology Diabetes and ObesityLippincott Williams & Wilkins · United Kingdom | 1.71Q1 | 3.08no 2007 value | 72 | 7% | — | — | |
15Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 1.70Q1 | 3.52 0.11 up from 2007 | 172 | 15% | $3,540 | ||
16The Aging MaleOAInforma · United Kingdom | 1.61Q1 | 3.49 0.71 up from 2007 | 58 | 100% | $2,557 | ||
17Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.54Q1 | 4.27 0.26 up from 2007 | 224 | 15% | $4,780 | ||
18Diabetic MedicineWiley · United Kingdom | 1.54Q1 | 3.85 0.20 down from 2007 | 828 | 23% | $4,870 | ||
19Clinical EndocrinologyWiley · United Kingdom | 1.50Q1 | 3.44 0.51 down from 2007 | 927 | 22% | $4,250 | ||
20Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.50Q1 | 3.27 0.26 down from 2007 | 182 | 4% | $3,760 | ||
21Lipids in Health and DiseaseOABioMed Central · United Kingdom | 1.47Q1 | 3.11 0.51 up from 2007 | 95 | 100% | $2,990 | ||
22Journal of EndocrinologyBioscientifica · United Kingdom | 1.47Q1 | 3.29 0.14 down from 2007 | 767 | 88% | — | ||
23Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.44Q1 | 3.81 0.19 up from 2007 | 401 | 12% | — | ||
24Endocrine Metabolic & Immune Disorders - Drug TargetsBentham Science Publishers · Netherlands | 1.38Q2 | 3.11 0.29 up from 2007 | 75 | 11% | — | ||
25Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 1.38Q2 | 3.26 0.60 up from 2007 | 319 | 8% | $3,000 | ||
26Diabetes and Vascular Disease ResearchOASAGE Publishing · United Kingdom | 1.35Q2 | 2.81 0.31 down from 2007 | 122 | 42% | $2,100 | ||
27Pediatric DiabetesWiley · Denmark | 1.28Q2 | 3.41 0.68 up from 2007 | 197 | 60% | $2,740 | ||
28Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 1.27Q2 | 3.45 0.18 up from 2007 | 265 | 10% | — | ||
29ThyroidMary Ann Liebert, Inc. · United States | 1.27Q2 | 3.21 0.03 up from 2007 | 612 | 14% | — | ||
30Diabetes & MetabolismElsevier BV · Netherlands | 1.21Q2 | 2.82 0.16 up from 2007 | 271 | 1% | $4,490 | ||
31Gender MedicineElsevier BV · United States | 1.16Q2 | 2.38 0.14 up from 2007 | 116 | 16% | — | ||
32The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 1.15Q2 | 2.58 0.58 down from 2007 | 205 | 15% | $4,400 | ||
33Hormone Research in PaediatricsKarger Publishers · Switzerland | 1.14Q2 | 2.68 0.18 down from 2007 | 440 | 30% | — | ||
34EndocrineSpringer Science+Business Media · United States | 1.09Q2 | 2.34 0.55 down from 2007 | 319 | 18% | $3,090 | ||
35Acta DiabetologicaSpringer Science+Business Media · Germany | 1.08Q2 | 1.83 1.15 down from 2007 | 94 | 8% | $4,590 | ||
36Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 1.06Q2 | 2.59 0.19 up from 2007 | 792 | 4% | $4,410 | ||
37Current Diabetes ReportsSpringer Science+Business Media · United States | 1.04Q2 | 2.00 0.27 down from 2007 | 217 | 6% | $4,890 | ||
38Treatments in EndocrinologySpringer Nature · New Zealand | 1.04Q2 | 1.97 0.49 down from 2007 | 74 | — | — | ||
39ClimactericTaylor & Francis · United Kingdom | 1.03Q2 | 2.65 0.04 up from 2007 | 192 | 7% | — | ||
40Hormone and Metabolic ResearchThieme Medical Publishers (Germany) · Germany | 1.01Q2 | 2.62 0.21 up from 2007 | 473 | 4% | — | ||
41The International Journal of Lower Extremity WoundsSAGE Publishing · United States | 1.00Q2 | 2.06 0.36 up from 2007 | 79 | 4% | $4,150 | ||
42Endocrine PracticeElsevier BV · United States | 0.97Q2 | 2.44 0.33 up from 2007 | 360 | 4% | $3,480 | ||
43MaturitasElsevier BV · Netherlands | 0.97Q2 | 2.48 0.09 up from 2007 | 412 | 18% | $4,390 | ||
44Growth Hormone & IGF ResearchElsevier BV · United Kingdom | 0.95Q2 | 2.34 0.24 down from 2007 | 207 | 3% | $3,570 | ||
45PituitarySpringer Science+Business Media · Netherlands | 0.91Q2 | 2.27 0.36 up from 2007 | 162 | 10% | $4,490 | ||
46PeptidesElsevier BV · United States | 0.87Q3 | 2.65 0.03 up from 2007 | 1,078 | 18% | $3,710 | ||
47Nature Clinical Practice Endocrinology & MetabolismNature Portfolio · United Kingdom | 0.84Q3 | 1.81 0.57 up from 2007 | 642 | 16% | — | ||
48Endocrine PathologySpringer Science+Business Media · United States | 0.82Q3 | 2.06 0.71 up from 2007 | 118 | 7% | $3,190 | ||
49Journal of Endocrinological InvestigationSpringer Science+Business Media · Italy | 0.80Q3 | 2.01 0.03 up from 2007 | 534 | 4% | $4,790 | ||
50The Journal of the British Menopause SocietySAGE Publishing | 0.76Q3 | 0.67 0.33 down from 2007 | 32 | — | — |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery474
- Pulmonary and Respiratory Medicine199
- Cardiology and Cardiovascular Medicine173
- Public Health, Environmental and Occupational Health173
- Oncology127
- Epidemiology114
- Infectious Diseases106
- Psychiatry and Mental health98
- Radiology, Nuclear Medicine and Imaging94
- Endocrinology, Diabetes and Metabolism89
- Physiology89
- Neurology85
- Orthopedics and Sports Medicine60
- Pediatrics, Perinatology and Child Health60
- Ophthalmology55
- Hematology52
- Dermatology50
- Obstetrics and Gynecology45
- Rheumatology38
- Nephrology33
- Pharmacology32
- Reproductive Medicine32
- Emergency Medicine29
- Complementary and alternative medicine28
- Geriatrics and Gerontology24
- Otorhinolaryngology21
- Pathology and Forensic Medicine18
- Rehabilitation18
- Immunology and Allergy15
- Critical Care and Intensive Care Medicine14
- Genetics11
- Anesthesiology and Pain Medicine9
- Hepatology9
- Urology8
- Gastroenterology7
- Internal Medicine4
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2008. Corpus-wide, 71.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
31 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2005–2007, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2008. Publication window: 2005–2007. How these summaries are calculated
- Ranked journals
- 89
- Window papers (baseline)
- 40,740 +35.5% from indicator year 2005
- Median OJR
- 0.91 +11.8% from indicator year 2005
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2005–2007 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.